Online mattress retailer Casper Sleep is looking to hire underwriters for an initial public offering that would allow Target to exit two years after leading its $170m series C round.

Hookipa Pharma, a Boehringer Ingelheim, Takeda and Gilead-backed infectious disease and cancer drug developer, has filed for an $86.3m IPO.

NetScientific has exited its loss-making portfolio companies Vortex and Wanda after originally deciding to close the two medical diagnostics ventures last week.

Baidu, Deutsche Telekom, Naver, New York Times and ProSiebenSat.1 are all set to exit the machine learning software provider in an acquisition by McDonald’s.

Profitable video conferencing technology provider Zoom has filed to go public, with Qualcomm Ventures set to record an exit.

Careem has agreed to an acquisition by Uber in a cash-and-convertible note deal, allowing Rakuten, Al Tayyar, Daimler, STC and Didi Chuxing to exit.

Eli Lilly and GlaxoSmithKline-backed cancer treatment developer Turning Point Therapeutics has filed to raise up to $100m having secured $145m in VC funding.

The Rakuten-backed social media company, which was valued at more than $12bn in 2017, has filed to list on the New York Stock Exchange.

Brainlab has purchased the surgical robotics technology provider for an undisclosed amount, two years after investing in the company.

The two rivalling US-based ride hailing platforms Uber and Lyft, both counting many corporates among their backers, are preparing to float on public markets in the coming weeks, with the valuations of the two combined likely to stand well above $100bn